Impheng et al. present the development of a novel highly specific inhibitor of tubulin detyrosination that can reverse the epithelial to mesenchymal transition in lung cancer cells.

Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transition in lung cancer cells
Impheng et al. Proc Natl Acad Sci USA 2026
https://www.pnas.org/doi/abs/10.1073/pnas.2514990123

Krzysztof Rogowski – Tubulin code